Trial Details
AuthorisedBasic Information
| Clinical ID | c2801 |
|---|---|
| Identifier | EUCTR2012-005644-26-BE |
| Trial Title | Prospective Open Label study of Parenteral vs Enteral iron in Young IBD patients and Effect on physical fitness - POPEYE study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Anemia and fatigue in children with Inflammatory Bowel disease (IBD);Therapeutic area: Body processes [G] - Digestive System and Oral Physiological Phenomena [G10] |
| Interventions | Trade Name: Injectafer /ferinject. Pharmaceutical Form: Concentrate and solvent for solution for injection/infusion INN or Proposed INN: FERRIC CARBOXYMALTOSE CAS Number: 9007-72-1 Current Sponsor code: Injectafer 50 mg/ml ijzer/ml oplossing voor injectie/infusie Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 50- Trade Name: Ferrofumaraat Apotex Product Name: ferrofumaraat Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Ferrous Fumarate CAS Number: 141-01-5 Current Sponsor code: ferrofumaraat Other descriptive name: FERROUS FUMARATE Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 100- |
Participant Information
| Sponsor | Atrium Medical Centre |
|---|---|
| City | - |
| Country/Region | Belgium;Netherlands |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |